ArticleBioengineered2024
Statement of Retraction: Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.